December 2nd 2024
If granted, guselkumab will be approved to treat children ages 6 and younger with severe plaque psoriasis and children ages 5 and younger with juvenile psoriatic arthritis.
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Billing for Mohs procedures, warts, ulcers
December 1st 2005Q I billed Medicare for the following services. All of the Mohs procedures were denied. Patient was in a 90-day postoperative period for a flap that was done 20 days earlier. Tell me how I should have coded to avoid the denials of my Mohs services?
Antiviral drugs effectively manage herpes infection in children, adults
December 1st 2005National report — Children infected with herpes simplex virus can be safely treated with valacyclovir — an antiviral commonly prescribed to treat adult herpes infection, according to research by Richard F. Jacobs, M.D., F.A.A.P., a pediatric infectious disease specialist at Arkansas Children's Hospital.
New pediatric research beacon for larger studies
December 1st 2005Harrison Hot Springs, British Columbia — According to Robert Sidbury, M.D., two of the most important pediatric studies published this year investigated the alleged connection between isotretinoin and depression, thoughts of suicide and even suicide itself among some teenage users being treated for acne.
Patient instruction essential to effective acne medication application
November 1st 2005Proper application consists of placing a "fingertip unit" of medication at each of 10 spots on the face — two on the mid-forehead (left and right), one each on the tip of the nose and chin, two spaced across each cheek, and one on each side of thelower face at a location that is approximately mid-distance between the spots on the cheek.
New bankruptcy laws make old asset protection planning obsolete
November 1st 2005What effect, if any, has the new bankruptcy act had on physician's asset protection plans? In short, the answer is "a significant one." In this article, we will explain exactly what this effect has been and why it is so important for all physicians to re-examine their planning because of it.
FDA to Review Diaper-Dermatitis Ointment for Approval
November 1st 2005Washington--The Food and Drug Administration has notified Barrier Therapeutics that it has deemed as a complete response the company's submission to address the FDA's May "not approvable" letter for Zimycan, a diaper-dermatitis ointment that contains miconazole nitrate.